Plandaí Biotechnology Management
Management criteria checks 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Key information
Roger Baylis-Duffield
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 23.3yrs |
CEO ownership | n/a |
Management average tenure | 7.1yrs |
Board average tenure | 12.2yrs |
Recent management updates
No updates
Recent updates
CEO
Roger Baylis-Duffield (80 yo)
23.3yrs
Tenure
US$5,305,000
Compensation
Mr. Roger Baylis-Duffield is Chairman of the Board and President at Protext Pharma, Inc. (FKA-Protext Mobility). He has been Chief Executive Officer of Protext Pharma, Inc. (FKA-Protext Mobility). since De...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 23.3yrs | US$5.31m | no data | |
President | 7.1yrs | US$382.50k | no data | |
Vice President of Sales and Marketing | 7yrs | no data | no data |
7.1yrs
Average Tenure
Equipo directivo experimentado: PLPLEl equipo directivo de la empresa es veterano y experimentado (6.8 años de antigüedad media).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | no data | US$5.31m | no data | |
President | 11.2yrs | US$382.50k | no data | |
Co-Founder & Director | no data | US$45.00k | no data | |
Chairman of the Scientific Board | 12.3yrs | US$1.94m | no data | |
Member of Scientific Board | 12.2yrs | no data | no data |
12.2yrs
Average Tenure
67yo
Average Age
Junta con experiencia: PLPLLos consejos de administración de la empresa son veteranos y experimentados ( 11.8 años de permanencia media en el cargo).